All posts tagged enzalutamide

  • Overwhelming evidence adds a major new target in breast cancer: androgens including testosterone. Image: Flickr/khrawlings

    In Triple-Negative Breast Cancer, Even Low-Androgen Tumors Respond to Anti-Androgen Therapy

    Valerie Barton, PhD candidate in the lab of CU Cancer Center researcher, Jennifer Richer, PhD, shows that even triple negative breast cancers with few androgen receptors respond to anti-androgen therapy.

Breast.Cancer.Pink
Flickr: Wolfram Burner
Jennifer Richer
Overwhelming evidence adds a major new target in breast cancer: androgens including testosterone. Image: Flickr/khrawlings
An aging population requires new approaches to prostate cancer care. Image: Flickr/PaulineMak
Like a burr, cancer cells wave receptors designed to trap things they need -- researchers hope that blocking the androgen receptors of AR+ breast cancer cells will stop the signals of growth. Image: Flickr/gomagoti
Harry Peterson, CU Cancer Center